Centene Corporation operates in the healthcare sector, providing managed care services to individuals and families. Its core products include Medicaid and Medicare programs, as well as health insurance plans for the uninsured. Major business segments encompass government-sponsored healthcare programs, with primary revenue sources derived from premiums and service fees. The company focuses on improving health outcomes and reducing costs through integrated care solutions.
Centene's stock is positioned for balanced investors, reflecting a focus on stability and moderate growth potential. The company has shown resilience in revenue growth, though it currently lacks a dividend yield. Its investment profile suggests a moderate risk level, appealing to those seeking a combination of growth and value without excessive volatility.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-09 02:36 | Buy | Hold | Strong momentum, but fundamentals show significant weakness. |
| 2026-05-30 02:35 | Hold | Buy | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-05-08 15:02 | — | Hold | Strong recent performance, but fundamentals show weakness. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-06-08 11:27 | Mizuho Securities | Target Raised | 58 → 63 | 62.33 |
| 2026-06-04 11:50 | Morgan Stanley | Target Raised | 50 → 57 | 59.55 |
| 2026-06-01 11:25 | Truist Financial | Target Raised | 58 → 71 | 59.585 |
